Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2677

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2413 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

24 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-OLMESARTAN 20MG TABLET Resolved 2018-10-22 2020-06-11 65350
TEVA-PRAZOSIN 5MG TABLET Resolved 2018-10-23 2019-04-27 65494
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65990
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
ACT METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65996
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999
TEVA-TELMISARTAN 40MG TABLET Resolved 2018-11-20 2019-04-11 67219
TEVA-TELMISARTAN 40MG TABLET Resolved 2018-11-20 2020-06-04 67222
TEVA-TELMISARTAN 80MG TABLET Resolved 2018-11-20 2020-05-08 67225
TEVA-TELMISARTAN 80MG TABLET Resolved 2018-11-20 2020-05-08 67228
TEVA-TELMISARTAN 80MG TABLET Resolved 2018-11-20 2020-05-14 67231
TEVA-TELMISARTAN HCTZ 12.5MG 80MG TABLET Resolved 2018-11-20 2019-04-27 67234
TEVA-TELMISARTAN HCTZ 12.5MG 80MG TABLET Resolved 2018-11-20 2019-07-15 67237
TEVA-TELMISARTAN HCTZ 12.5MG 80MG TABLET Resolved 2018-11-20 2019-04-27 67240
TEVA-TELMISARTAN HCTZ 25.0MG 80.0MG TABLET Resolved 2018-11-20 2019-03-12 67243
TEVA-TELMISARTAN HCTZ 25.0MG 80.0MG TABLET Resolved 2018-11-20 2019-03-12 67246
TEVA-AMPHETAMINE XR 2.5MG 2.5MG 2.5MG 2.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-11-30 2019-01-31 68265
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-17 68569
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-10 68572
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2020-02-13 68577

Showing 561 to 580 of 2677

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ENALAPRIL 8MG TABLET Discontinued 2018-10-19 2018-10-19 64861
TEVA-ENALAPRIL 16MG TABLET Discontinued 2018-10-19 2018-10-19 64866
TEVA-ENALAPRIL 4MG TABLET Discontinued 2018-10-19 2018-10-19 64869
ACT DONEPEZIL ODT 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-10-19 2018-10-19 64872
ACT DONEPEZIL ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-10-19 2018-10-19 64875
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2018-10-19 2018-10-19 64909
RATIO-TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Discontinued 2018-10-19 2018-10-19 64917
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
TEVA-CLONAZEPAM 0.5MG TABLET Discontinued 2018-10-19 2018-10-19 64923
TEVA-CLONAZEPAM 0.5MG TABLET Discontinued 2018-10-19 2018-10-19 64926
TEVA-CLONAZEPAM 2MG TABLET Discontinued 2018-10-19 2018-10-19 64929
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2018-10-19 2018-10-19 64970
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2018-10-19 2018-10-19 64975
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2018-10-19 2018-10-19 64983
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2018-10-19 2018-10-19 64993
TEVA-NORFLOXACIN 400MG TABLET Discontinued 2018-10-19 2018-10-19 65013
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2018-10-19 2018-10-19 65017
TEVA-TRIMEL DS 800MG 160MG TABLET Discontinued 2018-10-19 2018-10-19 65020
TEVA-TRIMEL DS 800MG 160MG TABLET Discontinued 2018-10-19 2018-10-19 65023

Showing 61 to 80 of 250